Amarin Corp. Plc (AMRN)
12.35
-0.37
(-2.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.38
+0.02
(+0.20%)
After-Hours: 20:00
Amarin Market Cap : 259.38M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 259.38M |
| October 01, 2026 | 267.15M |
| September 30, 2026 | 273.03M |
| September 29, 2026 | 275.97M |
| September 28, 2026 | 278.28M |
| September 25, 2026 | 277.23M |
| September 24, 2026 | 282.06M |
| September 23, 2026 | 288.15M |
| September 22, 2026 | 288.78M |
| September 21, 2026 | 283.11M |
| September 18, 2026 | 286.26M |
| September 17, 2026 | 291.30M |
| September 16, 2026 | 290.67M |
| September 15, 2026 | 292.56M |
| September 14, 2026 | 294.03M |
| September 11, 2026 | 289.83M |
| September 10, 2026 | 294.87M |
| September 09, 2026 | 302.22M |
| September 08, 2026 | 299.28M |
| September 04, 2026 | 286.26M |
| September 03, 2026 | 287.94M |
| September 02, 2026 | 287.73M |
| September 01, 2026 | 290.78M |
| August 31, 2026 | 291.51M |
| August 28, 2026 | 293.40M |
| Date | Value |
|---|---|
| August 27, 2026 | 295.50M |
| August 26, 2026 | 301.91M |
| August 25, 2026 | 297.18M |
| August 24, 2026 | 290.67M |
| August 21, 2026 | 295.92M |
| August 20, 2026 | 295.29M |
| August 19, 2026 | 302.01M |
| August 18, 2026 | 296.76M |
| August 17, 2026 | 294.24M |
| August 14, 2026 | 295.50M |
| August 13, 2026 | 297.18M |
| August 12, 2026 | 295.29M |
| August 11, 2026 | 294.24M |
| August 10, 2026 | 296.34M |
| August 07, 2026 | 301.59M |
| August 06, 2026 | 299.49M |
| August 05, 2026 | 302.64M |
| August 04, 2026 | 302.43M |
| August 03, 2026 | 296.97M |
| July 31, 2026 | 299.49M |
| July 30, 2026 | 298.86M |
| July 29, 2026 | 297.39M |
| July 28, 2026 | 292.98M |
| July 27, 2026 | 289.73M |
| July 24, 2026 | 284.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 14.55B |
| Alkermes Plc | 6.995B |
| Liquidia Corp. | 2.552B |
| Akari Therapeutics Plc | 15.26M |
| DBV Technologies SA | 624.38M |
Market Cap Related Metrics
| PS Ratio | 1.385 |
| Price to Book Value | 0.5847 |
| Price to Free Cash Flow | 16.55 |
| Price | 12.35 |
| Earnings Yield | -10.51% |